The size of global Drug Discovery Informatics Market in terms of revenue was estimated to be worth $2.2 billion in 2020 and is poised to reach $3.5 billion by 2025, growing at a CAGR of 9.3% from 2020 to 2025. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.

Market growth is largely driven by factors such as the rising R&D expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery. However, the scarcity of skilled professionals and the high setup cost of informatics software are expected to limit market growth to a certain extent.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=64537381

Browse in-depth TOC on “Drug Discovery Informatics Market”

124 – Tables

32 – Figures

140 – Pages

Key Market Players

The major companies in the drug discovery informatics market include Jubilant Life Sciences Limited (India), Charles River Laboratories (US), IBM (US), Clarivate Analytics (US), and Accenture (Ireland). These players have adopted various growth strategies such as product launches, acquisitions, to increase their presence in the global drug discovery informatics market.

Jubilant Life Sciences (India) has marked its presence among the major players in the discovery informatics market. To sustain its position in the drug discovery informatics market, the company focuses on collaborations to emerge as a preferred provider of drug discovery informatics services. For instance, in 2017, the company collaborated with Orion Corporation to provide drug discovery services. Such collaborations help the company to achieve business growth as well as advertise its expertise in the drug discovery informatics market.

Charles River Laboratories (US) offers various services ranging from target discovery to candidate validation as a part of the drug discovery informatics segment. As one of the leading firms in the industry, Charles River Laboratories has numerous strengths that help it to thrive in the marketplace. The firm also has a successful track record of integrating complimentary firms via mergers and acquisitions. It has successfully integrated a large number of technology companies in the past few years to streamline its operations and build a reliable supply chain

Request Fress Sample Report:https://www.marketsandmarkets.com/requestsampleNew.asp?id=64537381

By function, the sequencing and target data analysis segment accounted for the largest share for the drug discovery informatics market.

The sequencing and target data analysis segment accounted for the largest share of the drug discovery informatics market for the function segment of the market in 2019. The large share of this segment can be attributed to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains.

By the end-user, the pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market.

The pharmaceutical companies segment accounted for the largest share of the drug discovery informatics market in 2019, and pharmaceutical companies are using these informatics software extensively for pre-clinical research & development, target identification, compound screening and lead identification, and streamlining their drug discovery process which is the major factor for driving the growth of this segment

By application, the drug development segment accounted for the largest share of the drug discovery informatics market.

The drug development segment accounted for the largest share of the drug discovery informatics market in 2019, large share of this segment is primarily attributed to the increasing investments in the research and development of new drug molecules and the growing need for time and cost optimization for drug discovery and development.

North America accounted for the largest share of the market.

The drug discovery informatics market is divided into four major regions-North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global drug discovery informatics market, closely followed by Europe. The large share of North America in the global market can be attributed to the presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies

Recent Developments:

• In May 2019, Jubilant selected the CDD Vault informatics platform as its discovery research informatics platform for five years
• In May, 2019, Dassault Systemes acquired Medidata Solution adding its & clinical expertise and cloud-based solutions to Dassault & portfolio
• In September 2019 Evotec collaborated with Takeda Pharmaceutical Company Limited to establish five drug discovery programs with clinical candidates from Evotec for further clinical development by Takeda across multiple therapy areas

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=64537381

Key questions addressed by the report:

• Who are the major players in the drug discovery informatics market?
• What are the regional growth trends and the largest revenue-generating regions in the drug discovery informatics market?
• What are the major drivers and challenges in the drug discovery informatics market?
• What are the major function segments in the drug discovery informatics market?
• What are the major end users in the drug discovery informatics market?